Quetiapine Fumarate Sustained Release Tablets
Treatment of schizophrenia: Quetiapine fumarate sustained-release tablet is effective for positive symptoms of schizophrenia, and also has a certain effect on negative symptoms. It can also reduce affective symptoms associated with schizophrenia, such as depression, anxiety, and cognitive deficits. Treatment of depressive episodes in bipolar disorder: Rapid control of depressive symptoms in patients with bipolar disorder is effective for both bipolar I and bipolar II patients.
【Generic Name】Quetiapine Fumarate Sustained-Release Tablets
【Approval No.】Zhengzi H20203418
【Usage and Dosage】The drug should be swallowed whole, not broken, chewed or crushed, regardless of food
【Age of use】18 years old or older, see manual for details
【Storage】Storage at room temperature, airtight
【Validity Period】36 months
【Manufacturer】Beijing Tianheng Pharmaceutical Research Institute Nanyang Tianheng Pharmaceutical Factory
【China General Distribution】Shenzhen Foncoo Pharmaceutical Co., Ltd.
*Note: Please be sure to fill in the information accurately and keep the communication open, we will get in touch with you as soon as possible